GlassScriptPhysician profile
Lindall A Perry
NPI 1720036072
$10,730.61
in general payments reported to CMS, 2019-2025
41 companies · $1,567 in 2025
The $1,567 reported for 2025 was more than what 84% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,741 · 2020: $448 · 2021: $1,102 · 2022: $1,807 · 2023: $2,299 · 2024: $1,766 · 2025: $1,567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,632.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,501.43 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,888.38 | 2019-2025 | |
| Janssen Biotech, INC. | $607.53 | 2020-2025 | Tremfya, Stelara, Simponi Aria |
| Regeneron Healthcare Solutions, INC. | $572.13 | 2019-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $512.32 | 2019-2025 | Olumiant, Taltz, Ebglyss |
| Ucb, INC. | $485.99 | 2019-2025 | Bimzelx |
| Genzyme Corporation | $349.35 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $340.22 | 2023-2025 | Sotyktu |
| Janssen Scientific Affairs, LLC | $265.61 | 2021-2022 | |
| Pfizer INC. | $256.02 | 2021-2025 | |
| Leo Pharma INC. | $229.70 | 2019-2025 | Adbry |
| Almirall LLC | $157.85 | 2019-2023 | Klisyri |
| Incyte Corporation | $128.80 | 2021-2024 | Opzelura |
| Dusa Pharmaceuticals, INC. | $115.81 | 2019 | |
| Sun Pharmaceutical Industries INC. | $114.19 | 2019-2024 | Blu-U |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $110.99 | 2023 | Vtama |
| Amgen INC. | $95.55 | 2020-2025 | Otezla, Otezla |
| Kyowa Kirin, INC. | $90.24 | 2023 | Poteligeo |
| Allergan, INC. | $89.37 | 2019-2022 | |
| Celgene Corporation | $86.61 | 2019 | |
| Kerecis Limited | $79.87 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Merz North America, INC. | $70.10 | 2019 | |
| Galderma Laboratories, L.P. | $67.03 | 2025 | Nemluvio |
| Dermira, INC. | $66.85 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.29 | 2022-2023 | Spevigo |
| Biofrontera INC. | $55.32 | 2022-2023 | Xepi, Bf-Rhodoled, Ameluz |
| Ani Pharmaceuticals, INC. | $54.47 | 2025 | Purified Cortrophin Gel |
| Fresenius Kabi USA, LLC | $38.80 | 2023-2024 | Idacio |
| Sandoz INC. | $28.06 | 2023-2024 | Hyrimoz |
| Genentech USA, INC. | $26.22 | 2019-2021 | |
| Convatec INC. | $22.01 | 2024 | |
| Botanix Sb INC | $19.69 | 2025 | Sofdra |
| Verrica Pharmaceuticals INC. | $19.44 | 2024 | Ycanth |
| Merck Sharp & Dohme LLC | $18.20 | 2022 | |
| Organogenesis INC. | $17.42 | 2024 | |
| Aclaris Therapeutics, INC. | $16.49 | 2019 | |
| Sensus Healthcare, INC. | $16.00 | 2019 | |
| Organon LLC | $14.70 | 2024 | |
| Epi Health, LLC | $14.04 | 2021 | |
| Misonix INC | $13.28 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $12.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindall Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.